Journal Name: The Lancet HIV
Journal Type: Q1
ISSN: 23523018
Country: United Kingdom
Subject Area and Category: Immunology and Microbiology Immunology Virology Medicine Epidemiology Infectious Diseases
Publisher: Elsevier Ltd
Research Ranking: 100
Publication Type: Journals
H-Index: 91
Coverage: 2014-2025
Editors-in-Chief: Peter Hayward
Research Impact Score: 20.9
Impact Factor: 16.07
SCIMAGO SJR: 4.506
APC Cost: $6,680 and $7,280,
Submission Link: https://www.journals.elsevier.com/the-lancet-hiv
Contact Email: p.hayward@lancet.com
Address: 7, Adam Street, Adelphi, W.C. 2
Overview
The Lancet HIV: A Premier Journal Advancing Global HIV Research
The Lancet HIV is a leading peer-reviewed medical journal dedicated to high-impact research, reviews, and commentary on all aspects of HIV and AIDS. As part of the prestigious Lancet family of journals, The Lancet HIV maintains a strong commitment to improving global health by publishing cutting-edge findings, shaping policy, and promoting evidence-based care in the ongoing fight against the HIV epidemic.
Launched in 2014, The Lancet HIV has quickly become a trusted resource for clinicians, researchers, policymakers, and advocates working in the field of HIV/AIDS. The journal covers a wide array of topics, including prevention, treatment, epidemiology, public health interventions, clinical trials, antiretroviral therapy, co-infections such as tuberculosis and hepatitis, health equity, and stigma reduction. By offering a platform for both original research and expert analysis, The Lancet HIV supports informed decision-making and fosters innovation in HIV care and prevention worldwide.
Key Features and Impact
The Lancet HIV is recognized for its rigorous peer-review process and commitment to scientific excellence. Each publication undergoes a thorough editorial and peer review, ensuring the integrity and reliability of its content. The journal’s editorial board includes prominent HIV researchers and clinicians, further emphasizing its credibility in the scientific community.
The journal boasts a high impact factor, reflecting its influence and reach within the field. Articles published in The Lancet HIV are widely cited and frequently shape clinical practice, public health guidelines, and policy at both national and international levels. The journal is indexed in major databases including PubMed, Scopus, and Web of Science, enhancing its visibility and accessibility to a global audience.
Global Reach and Accessibility
Understanding the global nature of the HIV epidemic, The Lancet HIV prioritizes content that addresses the diverse challenges faced by low-, middle-, and high-income countries. The journal actively seeks submissions from researchers working in high-burden regions and promotes studies that examine social determinants of health, marginalized populations, and community-based interventions.
In addition, The Lancet HIV supports open access for many of its articles, facilitating wider dissemination of critical knowledge. This approach ensures that healthcare providers, advocates, and decision-makers—regardless of geographic location or economic status—can access vital research needed to inform their work.
Driving Innovation and Policy Change
Beyond publishing research, The Lancet HIV serves as a platform for thought leadership in HIV policy and advocacy. Editorials and commentaries often address pressing issues such as funding priorities, human rights, healthcare disparities, and the future of HIV cure research. By amplifying diverse voices and challenging outdated paradigms, the journal plays a central role in shaping the global HIV response.
About
About The Lancet HIV – Leading Global Insights on HIV Research and Treatment
The Lancet HIV is a prestigious peer-reviewed medical journal dedicated to advancing global knowledge and understanding of HIV/AIDS. Launched in 2014 as part of The Lancet family of journals, it has quickly become a trusted and influential platform for cutting-edge research, clinical practice, public health policies, and innovative approaches to HIV prevention, diagnosis, treatment, and care.
Published by Elsevier, The Lancet HIV focuses exclusively on high-quality, original research and comprehensive reviews across all aspects of HIV and AIDS. The journal covers a wide range of topics, including epidemiology, clinical trials, vaccine development, antiretroviral therapy (ART), HIV co-infections (such as tuberculosis and hepatitis), and the social determinants of HIV health outcomes.
Trusted Source for HIV Research and Evidence-Based Medicine
As one of the world’s leading journals in the field of infectious diseases, The Lancet HIV plays a critical role in shaping global HIV strategies. It is indexed in major databases like PubMed, Scopus, and Web of Science, making it highly accessible to researchers, clinicians, policymakers, and public health professionals worldwide.
The journal features contributions from leading experts in virology, immunology, sexual health, and global health. It is known for its rigorous peer-review process and commitment to publishing research that meets the highest standards of scientific integrity and ethical responsibility.
Key Features of The Lancet HIV
-
Open Access Options: Many articles are available under open access, allowing broader dissemination of knowledge and findings.
-
Monthly Issues: The journal is published monthly, ensuring a steady stream of current and relevant information.
-
Global Perspective: The Lancet HIV places strong emphasis on research from both high-income and low- and middle-income countries, reflecting the global nature of the HIV epidemic.
-
Multidisciplinary Approach: Topics covered extend beyond clinical care to include behavioral science, health systems, social justice, and community engagement in HIV care.
Impact and Importance
With a high impact factor, The Lancet HIV is among the most influential journals in the field of HIV/AIDS. Its articles frequently inform WHO guidelines, national treatment protocols, and funding strategies from organizations like UNAIDS, PEPFAR, and the Global Fund.
By promoting open scientific dialogue and highlighting emerging challenges—such as HIV drug resistance, stigma, and health disparities—The Lancet HIV helps shape the future of HIV prevention and treatment strategies worldwide.
Scope
Scope of The Lancet HIV: A Comprehensive Overview
The Lancet HIV is a highly respected peer-reviewed journal that focuses on the latest research, clinical practices, and advancements in the field of HIV/AIDS. It is part of The Lancet family, a globally recognized medical journal that has been at the forefront of scientific publications for over 180 years. The Lancet HIV specifically provides an in-depth platform for the exploration of topics related to HIV prevention, treatment, epidemiology, and policy. This scope makes it an invaluable resource for researchers, clinicians, and policymakers working within the field of HIV/AIDS care.
Focus Areas of The Lancet HIV
The primary goal of The Lancet HIV is to publish cutting-edge research that significantly advances our understanding of HIV. The journal's scope includes a broad range of topics, including but not limited to:
-
HIV Prevention and Treatment
The journal is committed to presenting innovative strategies and clinical trials aimed at improving HIV prevention and treatment. This includes novel antiretroviral therapies, PrEP (pre-exposure prophylaxis), and the exploration of vaccine development. Additionally, The Lancet HIV covers advancements in treatment regimens, personalized medicine, and long-acting therapies that may improve the quality of life for people living with HIV. -
Global Epidemiology of HIV
A major focus of The Lancet HIV is understanding the global burden of HIV and the factors that influence its spread. The journal publishes studies on the epidemiology of HIV in different regions of the world, examining how social, economic, and cultural factors impact HIV transmission. Key topics include high-risk populations, HIV prevalence in sub-Saharan Africa, and the effects of socio-economic disparities on HIV-related health outcomes. -
HIV and Co-infections
Individuals living with HIV are often susceptible to other infectious diseases, such as tuberculosis and viral hepatitis. The Lancet HIV explores the intersection of HIV and co-infections, providing critical insights into how co-morbidities affect HIV progression and treatment. This area of research is crucial for developing comprehensive care models for HIV-positive individuals. -
HIV and Human Rights
The social dimensions of HIV are increasingly acknowledged, and The Lancet HIV addresses the intersection of HIV with human rights, stigma, and discrimination. The journal highlights the need for equitable access to care, as well as policy solutions to protect marginalized populations, such as sex workers, people who inject drugs, and men who have sex with men. Research on the impact of HIV criminalization laws and advocacy for supportive legal frameworks are integral parts of this focus. -
Innovative Research and Technology
Advances in technology and novel research methodologies also find a place in The Lancet HIV. From genomic studies to data analytics, the journal encourages research that integrates new technologies to better understand HIV dynamics, improve diagnostics, and enhance treatment outcomes. This includes the role of artificial intelligence and machine learning in predicting HIV progression and treatment responses. -
Policy and Global Health
The Lancet HIV plays an important role in shaping global health policy by publishing evidence-based recommendations and discussing the political and economic challenges in tackling the HIV epidemic. The journal advocates for global health policies that prioritize HIV prevention and treatment, promote international collaboration, and address the disparities that exist in healthcare systems worldwide.